Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 5
2013 3
2015 1
2016 4
2017 2
2018 14
2019 6
2020 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean horacek m[au] (100 results)?
How does the TRS 2°P score relate to real-world patients?
Bonaca MP, De Ferrari GM, Atar D, Bash LD, Lautsch D, Bohula EA, Horack M, Brudi P, Ferrieres J, Gitt AK. Bonaca MP, et al. Among authors: horack m. Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):72-74. doi: 10.1093/ehjcvp/pvy004. Eur Heart J Cardiovasc Pharmacother. 2018. PMID: 29554293 Free PMC article. No abstract available.
Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS).
Ferrières J, Lautsch D, Gitt AK, De Ferrari G, Toplak H, Elisaf M, Drexel H, Horack M, Baxter C, Ambegaonkar B, Brudi P, Toth PP. Ferrières J, et al. Among authors: horack m. Diabetes Obes Metab. 2018 Nov;20(11):2670-2674. doi: 10.1111/dom.13415. Epub 2018 Jul 10. Diabetes Obes Metab. 2018. PMID: 29888459 Free PMC article.
Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome.
Ferrières J, Lautsch D, Bramlage P, Horack M, Baxter CA, Ambegaonkar B, Toth PP, Poh KK, De Ferrari GM, Gitt AK. Ferrières J, et al. Among authors: horack m. Arch Cardiovasc Dis. 2020 Oct;113(10):617-629. doi: 10.1016/j.acvd.2020.05.013. Epub 2020 Aug 29. Arch Cardiovasc Dis. 2020. PMID: 32873522 Free article.
Low-Density Lipoprotein Cholesterol Target Attainment in Patients Surviving an Acute Coronary Syndrome in Thailand: Results From the Dyslipidaemia International Study (DYSIS) II.
Buddhari W, Uerojanaungkul P, Sriratanasathavorn C, Sukonthasarn A, Ambegaonkar B, Brudi P, Horack M, Lautsch D, Vyas A, Gitt AK. Buddhari W, et al. Among authors: horack m. Heart Lung Circ. 2020 Mar;29(3):405-413. doi: 10.1016/j.hlc.2019.02.193. Epub 2019 Mar 28. Heart Lung Circ. 2020. PMID: 31006593 Clinical Trial.
Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study.
Ferrières J, Lautsch D, Ambegaonkar BM, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Velkovski-Rouyer M, Horack M, Almahmeed W, Chiang FT, Poh KK, Elisaf M, Brudi P, Gitt AK. Ferrières J, et al. Among authors: horack m. Int J Cardiol. 2018 Nov 1;270:21-27. doi: 10.1016/j.ijcard.2018.06.008. Epub 2018 Jun 6. Int J Cardiol. 2018. PMID: 29934227 Free article.
Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world.
Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT, Poh KK, Brudi P, Ambegaonkar B. Gitt AK, et al. Among authors: horack m. Data Brief. 2018 May 1;18:1937-1940. doi: 10.1016/j.dib.2018.04.092. eCollection 2018 Jun. Data Brief. 2018. PMID: 29904698 Free PMC article.
36 results